System and Method for Automatically Optimizing Customer Communication

The European Patent Office published patent application EP4405882A1 for Google LLC, covering a system and method for automatically optimizing customer communication. The patent relates to AI and machine learning techniques for analyzing and improving customer interactions across multiple communication channels. No compliance deadlines or regulatory requirements are associated with this patent publication.

User and Intermediary Implementation Mechanisms for Digital Currencies

The European Patent Office published patent application EP4292036A1 for 'User and Intermediary Implementation Mechanisms for Digital Currencies' filed by National Currency Technologies, Inc. The patent, published March 25, 2026, covers IPC classifications G06Q 20/06, G06F 21/00, and H04L 9/40. The 38 designated states include all EU member states plus Switzerland, Norway, and other European jurisdictions. This is a routine patent publication bulletin entry with no compliance obligations for regulated entities.

Liposomal Irinotecan and Oxaliplatin Combination Therapy for Metastatic Pancreatic Cancer

The European Patent Office published patent application EP3791876A1 filed by Ipsen Biopharm Ltd., covering methods for treating metastatic pancreatic cancer using combination therapies comprising liposomal irinotecan and oxaliplatin. The application names eight inventors including Sarah Blanchette and Jonathan Fitzgerald. The patent designates all 31 EPC contracting states including Germany, France, UK, Italy, Spain, and the Netherlands.

Human Anti-IL-23 Antibodies, Compositions, Methods and Uses

The European Patent Office published patent application EP3760230A1 by Janssen Biotech, Inc. for human anti-IL-23 antibodies, compositions, methods, and therapeutic uses. The application was published March 25, 2026, with designations across 27 European member states including AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR.

Bile Acid Conjugates for Active Drug Delivery

The European Patent Office granted Patent EP3870230A1 to Finice S.r.l. covering novel bile acid conjugates and their derivatives designed for active drug delivery applications. The patent lists nine inventors and is valid across 31 designated European states including Germany, France, UK, Italy, and Spain. Pharmaceutical companies developing bile acid-based delivery systems should review this patent for freedom-to-operate considerations.

Multivalent Antibody Therapeutic Patent

The European Patent Office published patent EP3774885A2 granting Merus B.V. protection for multivalent antibody therapeutics. The patent covers antibodies targeting C07K 16/12, 16/18, 16/28, and 16/36 classifications for cancer treatment applications (A61P 35/00). The designation covers 31 European states including major markets.

Aryl-Aniline Compounds for Treatment of Skin Cancers

The European Patent Office published patent application EP3883553A1 for NFlection Therapeutics covering aryl-aniline and heteroaryl-aniline compounds for treatment of skin cancers. Co-applicants include H. Lee Moffitt Cancer Center & Research Institute. The patent was published March 25, 2026, designating 35 European contracting states.

Georgetown CCK inhibitors for hepatic fibrosis

The European Patent Office published patent application EP3876924A1 for Georgetown University covering CCK (cholecystokinin) inhibitors for treating non-alcoholic steatohepatitis (NASH) and hepatic fibrosis. The A1 publication indicates the application is now accessible with the international search report. Applicant: Georgetown University; Inventor: Jill P. Smith.

European Patent for Bladder Urine Control Apparatus

The European Patent Office published patent application EP4342518A2 for Holdica Ltd., covering an apparatus for controlling urine flow in the bladder or urethra. The patent application, classified under A61F 2/00 and A61N 1/36, designates multiple European member states including Germany, France, the United Kingdom, and other EU territories.

Conformable Sheath for Medical Implant Patent

The European Patent Office published patent EP4245256A1 for AdjuCor GmbH's conformable sheath designed for medical implants. The invention, classified under IPC A61F 2/00 and A61F 2/24, is validated across 31 European designated states including Germany, France, the United Kingdom, Italy, and other EU/EEA members. This patent grants AdjuCor exclusive rights to the conformable sheath technology for medical implants.